FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

325072002: Insulin aspart (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
465704013 Insulin aspart en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
718291019 Insulin aspart (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3488039019 Insulin aspart soluble en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
49301000195116 insulina aspartat it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
817901000172113 insuline asparte fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
63441000195118 Insulin aspart de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Insulin aspart Is a Insulin-containing product false Inferred relationship Some
Insulin aspart Is a Human insulin true Inferred relationship Some
Insulin aspart Is a Short-acting insulin false Inferred relationship Some
Insulin aspart This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Pancreatic hormone (disposition) true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
insuline aspart 100 unités/mL, flacon de 10 mL de solution injectable Is a False Insulin aspart Inferred relationship Some
insuline aspart 100 unités/mL, cartouche de 3 mL de solution injectable Is a False Insulin aspart Inferred relationship Some
Insulin aspart 100units/mL injection 3mL cartridge Is a False Insulin aspart Inferred relationship Some
insuline aspart 100 unités/mL, flacon de 10 mL de solution injectable The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Insulin aspart Inferred relationship Some
insuline aspart 100 unités/mL, cartouche de 3 mL de solution injectable The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Insulin aspart Inferred relationship Some
Insulin aspart 100units/mL prefilled pen The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Insulin aspart Inferred relationship Some
Insulin biphasic aspart 30/70 100units/mL injection cartridge 3mL The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Insulin aspart Inferred relationship Some
Insulin biphasic aspart 30/70 100units/mL injection prefilled pen 3mL The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Insulin aspart Inferred relationship Some
Product containing insulin aspart (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Insulin aspart Inferred relationship Some 1
Product containing insulin aspart and insulin aspart protamine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Insulin aspart Inferred relationship Some
Insulin aspart 100units/mL injection solution 3mL prefilled disposable injection device The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Insulin aspart Inferred relationship Some
Insulin aspart biphasic (recombinant human insulin analogue) 30/70 100units/ml injection 3ml pre-filled disposable injection device The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Insulin aspart Inferred relationship Some
Insulin aspart (recombinant human insulin analogue) 100units/ml injection 3ml cartridge The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Insulin aspart Inferred relationship Some
Insulin aspart biphasic (recombinant human insulin analogue) 30/70 100units/ml injection 3ml cartridge The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Insulin aspart Inferred relationship Some
Insulin aspart (recombinant human insulin analogue) 100units/ml inject The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Insulin aspart Inferred relationship Some
Insulin aspart protamine (substance) Is a False Insulin aspart Inferred relationship Some
Product containing insulin aspart and insulin degludec (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Insulin aspart Inferred relationship Some 1
Product containing insulin aspart and insulin degludec in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Insulin aspart Inferred relationship Some 1
Product containing insulin aspart in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Insulin aspart Inferred relationship Some 1
Insulin aspart protamine (substance) This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. False Insulin aspart Inferred relationship Some
Product containing precisely insulin aspart 1000 unit/10 milliliter conventional release solution for injection vial This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Insulin aspart Inferred relationship Some 1
Product containing precisely insulin aspart 1000 unit/10 milliliter conventional release solution for injection vial The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Insulin aspart Inferred relationship Some 1
Insulin aspart only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Insulin aspart Inferred relationship Some 1
Product containing only insulin aspart and insulin degludec (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Insulin aspart Inferred relationship Some 1
Insulin aspart and insulin degludec only product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Insulin aspart Inferred relationship Some 1
Product containing only insulin aspart in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Insulin aspart Inferred relationship Some 1
Insulin aspart 100 unit/mL solution for injection This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Insulin aspart Inferred relationship Some 1
Insulin aspart 100 unit/mL solution for injection The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Insulin aspart Inferred relationship Some 1
Product containing insulin aspart and insulin aspart protamine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Insulin aspart Inferred relationship Some 2
Insulin aspart and insulin aspart protamine only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Insulin aspart Inferred relationship Some 1

This concept is not in any reference sets

Back to Start